<?xml version="1.0" encoding="UTF-8"?>
<p id="Par22">Today, governments face a very urgent need for measures to tame of the rapid spread of SARS-CoV2. Hence, clinicians and researchers across the globe are actively engaged in identifying effective therapeutic strategies to curb this deadly disease. To rush through the pandemic, one option researchers proposed was to ‘repurpose’ drug that has worked for similar diseases, till herd immunity is achieved (Zumla et al. 
 <xref ref-type="bibr" rid="CR66">2016</xref>; Li and De Clercq 
 <xref ref-type="bibr" rid="CR29">2020</xref>). When COVID-19 was detected in Wuhan, China resorted to test the effectiveness of anti-viral drugs and other infectious diseases against COVID-19.
</p>
